<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The need for radical subtotal esophagectomy and extensive lymphadenectomy in patients with early Barrett <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, i.e. T1 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, is increasingly questioned </plain></SENT>
<SENT sid="1" pm="."><plain>Based on the principles of surgical <z:hpo ids='HP_0002664'>oncology</z:hpo>, the precancerous nature of <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo>, and the high rate of <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> in patients with T1b <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, the minimal extent of the procedure for early Barrett <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> must include the entire segment of the distal esophagus covered by <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> and a regional lymphadenectomy </plain></SENT>
<SENT sid="2" pm="."><plain>In adequately selected patients this can be achieved by a limited surgical procedure with transhiatal resection of the distal esophagus and jejunum interposition, but not by endoscopic mucosal ablation or endoscopic mucosa resection </plain></SENT>
<SENT sid="3" pm="."><plain>The high recurrence rates after endoscopic interventions does not support the use of these techniques in operable patients </plain></SENT>
</text></document>